The Go-To Experts for
Women’s Health Innovation

FemHealth Insights empowers business leaders to deeply understand the women’s health market and discover strategic opportunities to positively impact female health and wellness through custom consulting services, expert thought leadership, comprehensive market analysis, and direct access to the FemHealth startup community.

We work with:

  • Private equity firms

  • Venture capital funds

  • Corporate strategy teams

  • Pharmaceutical and device manufacturers

  • Global health funders

  • Women’s health startups

  • Non-Profits and Governments

Strategic Advisory Services

Stock photo or image featured in a FemHealth Insights article, showcasing femtech trends, innovation, research, and data in the women's health innovation and technology sector.

Most Requested Services

1. Health Vertical Landscaping

Comprehensive identification and evaluation of companies operating within a specific women’s health vertical.

Typical Deliverables Include:

  • Company mapping across stages (idea → public)

  • Product type analysis (CPG, digital, device, diagnostic, therapeutic)

  • Regulatory landscape review

  • Funding history analysis

  • Competitive positioning framework

Best For: Corporate market entry, investment thesis development, acquisition pipeline building.

3. Market Trends & Insights Reports

High-level strategic intelligence for decision makers entering or expanding within a women’s health vertical.

May Include:

  • Market size and growth analysis

  • Disease prevalence and demographic trends

  • Stakeholder ecosystem mapping

  • White space identification

  • Standard-of-care paradigms

  • Risk factor and unmet need analysis

  • Forward-looking trend predictions

Best For: Board-level decisions, strategic expansion, investor memos.

5. Global Health & Funding Strategy

Strategic advisory for organizations expanding into emerging markets or pursuing blended capital strategies.

May Include:

  • Investor mapping

  • Philanthropic funding identification

  • LMIC market entry feasibility

  • Stakeholder interviews

  • Risk analysis and implementation pathways

Best For: Global health funders, NGOs, multilaterals, and companies seeking scalable, financially viable expansion into emerging markets.

2. Competitive Deep Dives

In-depth analysis of 5–15 high-priority companies.

May Include:

  • Business model review

  • Clinical evidence evaluation

  • Revenue and commercialization strategy assessment

  • Messaging and brand positioning analysis

  • Existing partnerships and market traction

  • Executive team review

  • Warm founder introductions when appropriate

Best For: M&A diligence, partnership strategy, investor evaluations.

4. Scientific & Innovation Assessment

For clients evaluating scientific feasibility or novel approaches.

May Include:

  • Literature reviews

  • AI and emerging tech landscape analysis

  • Clinical research benchmarking

  • Regulatory and approval pathway mapping

  • Expert interviews

Best For: R&D planning, acquisition decisions, product expansion.

Logos of consulting clients and partner companies of FemHealth Insights, representing consulting client success in women's health.

Some of Our Highly Satisfied Current and Former Clients

Logos of consulting clients and partner companies of FemHealth Insights, representing consulting client success in women's health.
Logos of consulting clients and partner companies of FemHealth Insights, representing consulting client success in women's health.
Logos of consulting clients and partner companies of FemHealth Insights, representing consulting client success in women's health.
Logos of consulting clients and partner companies of FemHealth Insights, representing consulting client success in women's health.
Logo of consulting clients and partner companies of FemHealth Insights, representing consulting client success in women's health.
Logos of consulting clients and partner companies of FemHealth Insights, representing consulting client success in women's health.

Sample Engagements:

  • Scientific review of diagnostic potential using menstrual effluent, including expert interviews and acquisition strategy analysis.

  • U.S. market entry strategy for Asia-based hormone tracking device; identified fertility clinics as initial customer segment.

  • Gap assessment of chronic conditions disproportionately affecting females; recommended technology acquisition strategy.

  • Investor mapping and fundraising strategy for multipurpose contraceptive/HIV prevention therapeutic intended for African markets.

  • Market Analysis of female mental health, including hardware landscape and AR/VR future scenario modeling.

  • Competitive analysis and launch strategy evaluation for vaginal health CPG product entering U.S. retail.

  • Landscape review across maternal health and fertility for acquisition interest.

Uniquely Qualified

FemHealth Insights proudly defined femtech in 2020 from ‘women’s health innovation’ to ‘solutions to conditions that solely, disproportionately, or differently affect females, women, and girls’. In 2021, Femhealth Insights published the first comprehensive market evaluation report, showing that women’s health was worth at least $1.2 Trillion.

Our work is cited globally by top firms, including Frost and Sullivan, Accenture, Rock Health, Deloitte, and the Gates Foundation. We launched, operated, and sold the largest virtual community of women’s health founders. We maintain the largest database of femtech startups, have published over 240 podcast interviews, and have hosted over 5k attendees at virtual events, with a digital audience of 150k+.

The team is led by the well-respected Dr. Brittany Barreto, who has been at the forefront of the femtech movement since 2019. Women’s health is broad and diverse, so every project is led by Dr. Barreto, with a team of consultants recruited to specialize in the specific market or health vertical the client is interested in.